Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau

Vaccine

Volumn 32, Issue 5, 2014, Pages 598-605

  Fisker, Ane Bærent ^a,b   Ravn, Henrik ^a,b   Rodrigues, Amabelia ^a   Østergaard, Marie Drivsholm ^a   Bale, Carlito ^a   Benn, Christine Stabell ^a,b   Aaby, Peter ^a,b  

^a Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Child mortality; Diphtheria tetanus pertussis vaccine; Measles vaccine; Pentavalent vaccine; Yellow fever vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES VACCINE; PLACEBO; RETINOL; YELLOW FEVER VACCINE;

ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; FEMALE; GUINEA-BISSAU; HEALTH PROGRAM; HUMAN; INFANT; LOWEST INCOME GROUP; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RURAL AREA; URBAN AREA; VACCINATION;

BACILLUS CALMETTE-GUÉRIN VACCINE; BANDIM HEALTH PROJECT; BCG; BHP; CHILD MORTALITY; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DTP; EPI; EXPANDED PROGRAMME ON IMMUNISATIONS; HDSS; HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM; MEASLES VACCINE; MORTALITY RATE RATIO; MRR; MV; OPV; ORAL POLIO VACCINE; PENTAVALENT VACCINE; YELLOW FEVER VACCINE; YF;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; GUINEA-BISSAU; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MEASLES VACCINE; MORTALITY; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINATION; VACCINES, INACTIVATED; VITAMIN A; YELLOW FEVER VACCINE;

EID: 84891659310     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.074     Document Type: Article

References (43)

1. UNICEF, World Health Organization Immunisation summary: a statistical reference containing data through 2009 2011, Available from: http://www.childinfo.org/files/32775_UNICEF.pdf.
2. Burton A., Monasch R., Lautenbach B., Gacic-Dobo M., Neill M., Karimov R., et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009, 87:535-541.
3. Global routine vaccination coverage, 2010. Wkly Epidemiol Rec 2011, 86:509-513.
4. GAVI GAVI Alliance progress report 2010 2011, Available from: http://www.gavialliance.org/results/gavi-progress-reports/.
5. Kristensen I., Aaby P., Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000, 321:1435-1438.
6. Roth A., Jensen H., Garly M.-L., Djana Q., Martins C.L., Sodemann M., et al. Low birth weight infants and Calmette-Guérin Bacillus vaccination at birth. Pediatr Infect Dis J 2004, 23:544-550.
7. Aaby P., Martins C.L., Garly M.L., Bale C., Andersen A., Rodrigues A., et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010, 341:c6495.
8. Aaby P., Benn C.S. Non-specific and sex-differential effects of routine vaccines: what evidence is needed to take these effects into consideration in low-income countries. Human Vaccin 2011, 7:120-124.
9. Aaby P., Benn C., Nielsen J., Lisse I.M., Rodrigues A., Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012, 2:e000707.
10. Hornshoj L., Benn C.S., Fernandes M., Rodrigues A., Aaby P., Fisker A.B. Vaccination coverage and out-of-sequence vaccinations in rural Guinea-Bissau: an observational cohort study. BMJ Open 2012, 2:e001509.
11. Clark A., Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009, 373:1543-1549.
12. Aaby P., Ibrahim S.A., Libman M.D., Jensen H. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa. Vaccine 2006, 24:2764-2771.
13. Aaby P., Jensen H., Walraven G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 2006, 24:4701-4708.
14. Aaby P., Vessari H., Nielsen J., Maleta K., Benn C.S., Jensen H., et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006, 25:721-727.
15. Hirve S., Bavdekar A., Juvekar S., Benn C.S., Nielsen J., Aaby P. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine 2012, 30(50):7300-7308.
16. Agergaard J., Nante E., Poulstrup G., Nielsen J., Flanagan K.L., Ostergaard L., et al. Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. Vaccine 2011, 29:487-500.
17. Fine P.E., Smith P.G. 'Non-specific effects of vaccines' - an important analytical insight, and call for a workshop. Trop Med Int Health 2007, 12:1-4.
18. Aaby P., Benn C.S. Assessment of childhood immunisation coverage. Lancet 2009, 373:1428.
19. Fisker AB, Hornshoj L, Rodrigues A, Balde I, Fernandes M, Benn CS, et al. International policy drives mixed effects on the ground: Increased coverage of DTP-3 and reduced coverage for measles vaccine after the introduction of new vaccines in Guinea-Bissau. 2013.
20. GAVI Proposal for NVS - YF, Penta support: Guinea-Bissau. Approved by GAVI on 01-08-2007 2007, GAVI Alliance, Available from: http://www.gavialliance.org/country/guinea-bissau/documents/#approvedproposal.
21. Benn C.S., Bale C., Sommerfelt H., Friis H., Aaby P. Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines?. Int J Epidemiol 2003, 32:822-828.
22. Fisker AB, Bale C, Rodrigues A, Balde I, Fernandes M, Jorgensen MJ, et al. A randomised trial of high-dose vitamin A at vaccination contacts after 6 months of age. 2013 [under review].
23. Fisker A.B., Bale C., Jorgensen M.J., Balde I., Hornshoj L., Bibby B.M., et al. High-dose vitamin A supplementation administered with vaccinations after 6 months of age: sex-differential adverse reactions and morbidity. Vaccine 2013, 31:3191-3198.
24. World Health Organization.Multicentre Growth Reference Study Group WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development 2006, World Health Organisation, Geneva.
25. World Health Organization WHO Anthro (version 3.1, June 2010) and macros 2010.
26. Jensen H., Benn C.S., Lisse I.M., Rodrigues A., Andersen P.K., Aaby P. Survival bias in observational studies of the impact of routine immunizations on childhood survival. Trop Med Int Health 2007, 12:5-14.
27. Aaby P., Ravn H., Roth A., Rodrigues A., Lisse I.M., Diness B.R., et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child 2012, 97:685-691.
28. Bale C., Garly M.L., Martins C., Nielsen J., Whittle H., Aaby P. Risk factors for measles in young infants in an urban African area with high measles vaccination coverage. Pediatr Infect Dis J 2011, 30:689-693.
29. Austin P.C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009, 28:3083-3107.
30. Williamson E., Morley R., Lucas A., Carpenter J. Propensity scores: from naive enthusiasm to intuitive understanding. Stat Methods Med Res 2012, 21:273-293.
31. Benn C.S., Aaby P., Nielsen J., Binka F.N., Ross D.A. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial. Am J Clin Nutr 2009, 90:629-639.
32. Aaby P., Jensen H., Samb B., Cisse B., Sodemann M., Jakobsen M., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003, 361:2183-2188.
33. Aaby P., Biai S., Veirum J.E., Sodemann M., Lisse I., Garly M.L., et al. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau. Vaccine 2007, 25:1265-1269.
34. Jahn A., Floyd S., Mwinuka V., Mwafilaso J., Mwagomba D., Mkisi R.E., et al. Ascertainment of childhood vaccination histories in northern Malawi. Trop Med Int Health 2008, 13:129-138.
35. Marshall R., Habicht J.P., Landrigan P.J., Foege W.H., Delgado H. Effectiveness of measles vaccine given simultaneously with DTP. J Trop Pediatr Environ Child Health 1974, 20:126-129.
36. McBean A.M., Gateff C., Manclark C.R., Foster S.O. Simultaneous administration of live attenuated measles vaccine with DTP vaccine. Pediatrics 1978, 62:288-293.
37. Deforest A., Long S.S., Lischner H.W., Girone J.A., Clark J.L., Srinivasan R., et al. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics 1988, 81:237-246.
38. Biai S., Rodrigues A., Nielsen J., Sodemann M., Aaby P. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. Vaccine 2011, 29:3662-3669.
39. van der Sande M.A., Mendy M., Waight P., Doherty C., McConkey S.J., Hall A.J., et al. Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. Vaccine 2007, 25:1509-1512.
40. Griffiths U.K., Clark A., Gessner B., Miners A., Sanderson C., Sedyaningsih E.R., et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. Epidemiol Infect 2012, 140:1343-1355.
41. Bisgard K.M., Rhodes P., Connelly B.L., Bi D., Hahn C., Patrick S., et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005, 116:e285-e294.
42. Muller A.S., Leeuwenburg J., Voorhoeve A.M. Pertussis in a rural area of Kenya: epidemiology and results of a vaccine trial. Bull World Health Organ 1984, 62:899-908.
43. Nielsen A.M., Larsen S.O., Zoffmann H. Whooping cough in Denmark among children under 1 year of age during 1980-1986. Ugeskr Laeger 1991, 153:1482-1485.